Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma (Q95762094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

title

Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

Kim H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Sohn HJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Kim S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Lee JS

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Kim WK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Suh C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

30 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

page(s)

1037-1042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

30 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Management of multiple myeloma: a systematic review and critical appraisal of published studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Immune recovery after autologous or rhG-CSF primed PBSC transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Immune recovery after bone marrow and peripheral blood stem cells transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Dendritic cell recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705373

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708062%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference